undamentalytics Newsletter

Shackelton Christopher S: insider trades

Director, 10% owner at 7 companies we cover. 7 open-market purchases and 8 sales not made under a pre-set plan, reported from August 26, 2015 to February 25, 2026.

Would copying Shackelton Christopher S’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 5 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on December 21, 2021 into $7,242 by November 2, 2026, −6.5% a year. The copy held shares only 72% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $13,871, +7.0% a year (the S&P 500 held throughout made $17,406, +12.1% a year). Beta against the index was 1.29. Twelve months after each report, the average purchase was −10.8% against the S&P 500 (median −17.1%), and 40% beat it. Measured from the trade date, the insider’s own timing, the average was −7.2%. After their sales, the shares moved +29.6% against the index over 12 months on average (a negative figure means selling was the right call); 43% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$5.0k$10.0k$15.0k 202120222023202420252026 $17.4k$13.9k$7.2k
Copying Shackelton Christopher SS&P 500, same days investedS&P 500, held throughout $10,000 copying Shackelton Christopher S’s open-market purchases from December 21, 2021, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−6.5%
S&P 500, same days invested
+7.0% (held throughout +12.1%)
Time in shares
72%
Sharpe ratio (S&P 500)
0.10 (0.51)
Biggest drop (S&P 500)
−80% (−25%)
Market sensitivity (beta)
1.29
Purchases copied
6

Trade by trade

Shackelton Christopher S: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 6 −4.9% −7.5% 33% 5 −0.50 0.64 No reliable evidence
Purchases, 6 months after the report 6 −1.0% −9.7% 33% 5 −0.04 0.97 No reliable evidence
Purchases, 12 months after the report 5 −10.8% −17.1% 40% 4 −0.07 0.95 No reliable evidence
Purchases, 12 months after the trade 5 −7.2% −14.5% 40% 4 0.00 1.00 No reliable evidence
Sales, 3 months after the report 7 −4.3% −2.6% 71% 4 −2.58 0.081 No reliable evidence
Sales, 12 months after the report 7 +29.6% +11.9% 43% 4 1.55 0.22 No reliable evidence
Sales, 12 months after the trade 7 +26.9% +4.7% 43% 4 1.37 0.26 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Blue Bird Corp BLBD —04March 22, 2017June 14, 2023
Universal Technical Institute Inc UTI —13June 23, 2023May 29, 2025
Option Care Health, Inc. OPCH —11August 26, 2015August 17, 2017
Sonos Inc SONO —20June 24, 2025February 25, 2026
Purple Innovation, Inc. PRPL —10December 20, 2021December 20, 2021
Mastercraft Boat Holdings, Inc. MCFT —10December 30, 2024December 30, 2024
Accendra Health Inc ACH —10March 4, 2025March 4, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
February 25, 2026February 23, 2026 SONO Purchase $9,140,036 −9.1%not yetnot yet
June 24, 2025June 20, 2025 SONO Purchase $4,245,197 +31.7%+4.8%+18.1%
May 29, 2025May 27, 2025 UTI Sale $17,500,000 −34.9%−13.1%−20.0%
March 4, 2025February 28, 2025 ACH Purchase $27,386,158 −34.1%−92.4%−90.8%
February 11, 2025February 10, 2025 UTI Sale $19,877,644 +23.1%−3.6%−22.5%
December 30, 2024December 26, 2024 MCFT Purchase $3,543,949 −5.8%−17.1%−14.5%
February 16, 2024February 15, 2024 UTI Sale $59,544,226 −8.5%+56.4%+72.4%
June 23, 2023June 21, 2023 UTI Purchase $2,052,138 +29.2%+96.9%+90.1%
June 14, 2023June 12, 2023 BLBD Sale $69,000,000 −10.6%+131.3%+139.4%
December 20, 2021December 16, 2021 PRPL Purchase $85,149,945 −41.1%−46.1%−38.9%
August 17, 2017August 15, 2017 OPCH Sale $2,732,330 not yetnot yetnot yet
June 20, 2017June 16, 2017 BLBD Sale $3,954,240 +5.3%+11.9%+4.7%
May 18, 2017May 16, 2017 BLBD Sale $2,413,337 −2.6%−4.1%−8.9%
March 22, 2017March 20, 2017 BLBD Sale $8,747,690 −1.6%+28.4%+23.3%
August 26, 2015August 24, 2015 OPCH Purchase $1,484,266 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Shackelton Christopher S traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.